Seeking Alpha
 

Baxter International Inc (BAX)

- NYSE
  • Mon, May 18, 3:03 PM
    • Goldman's sees the S&P 500 hitting a mid-year high of 2,150 by mid-year, but fading to 2,100 by year-end after the Fed hikes rates. Its 12-month forecast of 2,125 stands against the current level of 2,130.
    • With appreciation returns expected to be nil, Goldman suggests having a look at its dividend growth portfolio - a sector-neutral basket of 50 stocks. They have a median yield of 2.5% and are expected to boost payouts by 16% this year and 12% in 2016. The group's P-E ratio is 15 vs. 17.3 for the S&P 500.
    • The ten highest-yielding additions: Harley-Davidson (NYSE:HOG) - with a 2.3% yield, Home Depot (NYSE:HD) - 2.1%, Dr. Pepper Snapple (NYSE:DPS) - 2.5%, National Oilwell Varco (NYSE:NOV) - 3.6%, Regions Financial (NYSE:RF) - 2.3%, Baxter International (NYSE:BAX) - 3.1%, Cummins (NYSE:CMI) - 2.4%, Seagate Technology (NASDAQ:STX) - 3.9%, International Paper (NYSE:IP) - 3.1%, AES Corp (NYSE:AES) - 3%.
    • Looking over a ten-year horizon, Goldman expects dividends to account for 46% of the S&P 500's 5% annualized return, up from 20% during the current bull market which started in 2009.
    • ETFs: DVY, SCHD, ADX, SDOG, DLN, DHS, FDL, DTD, FVD, DVYL, SDYL
    | 17 Comments
  • Tue, May 5, 8:57 AM
    • Baxter (NYSE:BAX) declares $0.52/share quarterly dividend, in line with previous.
    • Forward yield 2.97%
    • Payable July 1; for shareholders of record June 1; ex-div May 28.
    | 6 Comments
  • Tue, Feb. 17, 10:09 AM
    • Baxter (NYSE:BAX) declares $0.52/share quarterly dividend, in line with previous.
    • Forward yield 2.96%
    • Payable April 1; for shareholders of record March 11; ex-div March 9.
    | 3 Comments
  • Nov. 11, 2014, 9:09 AM
    | Comment!
  • Jul. 22, 2014, 9:03 AM
    • Baxter International (NYSE:BAX) declares $0.52/share quarterly dividend, in line with previous.
    • Forward yield 2.73%
    • Payable Oct. 1; for shareholders of record Sept. 5; ex-div Sept. 3.
    | Comment!
  • May 5, 2014, 4:45 PM
    • Baxter International Inc (BAX) declares $0.52/share quarterly dividend, 6.1% increase from prior dividend of $0.49.
    • Forward yield 2.79%
    • Payable July 1; for shareholders of record June 6; ex-div June 4.
    | Comment!
  • Feb. 18, 2014, 9:28 AM
    • Baxter International Inc (BAX) declares $0.49/share quarterly dividend, in line with previous.
    • Forward yield 2.84%
    • Payable April 1; for shareholders of record March 7; ex-div March 5.
    | Comment!
  • Nov. 12, 2013, 10:26 AM
    • Baxter International Inc (BAX) declares $0.49/share quarterly dividend, in line with previous
    • Forward yield 2.98%
    • Payable Jan 3; for shareholders of record Dec. 6; ex-div Dec. 4.
    | Comment!
  • Jul. 23, 2013, 5:49 PM
    Baxter International Inc (BAX) declares $0.49/share quarterly dividend, in line with prior. Forward yield 2.64%. For shareholders of record Sept. 6. Payable Oct. 1. Ex-div Sept. 4. (PR)
    | Comment!
  • May 7, 2013, 6:21 AM
    Baxter International (BAX) declares $0.49/share quarterly dividend, 9% increase from prior dividend of $0.45. Forward yield 2.56%. For shareholders of record June 07. Payable July 01. Ex-div date June 05. (PR)
    | Comment!
  • Feb. 19, 2013, 9:35 AM
    Baxter International Inc. (BAX) declares $0.45/share quarterly dividend, in line with previous. Forward yield 2.64%. For shareholders of record Mar. 08. Payable Apr. 01. Ex-div date Mar. 06. (PR)
    | Comment!
  • Nov. 13, 2012, 12:10 PM
    Baxter International Inc. (BAX) declares $0.45/share quarterly dividend, in line with previous. Forward yield 2.74%. For shareholders of record Dec. 7. Payable Jan 3. Ex-div Dec. 5. (PR)
    | Comment!
  • Jul. 25, 2012, 9:48 AM
    Baxter International (BAX) declares $0.45/share quarterly dividend, 34% increase from prior dividend of $0.335. Forward yield 3.15%. For shareholders of record Sep 07. Payable Oct 01. Ex-div date Sep 05. (PR)
    | Comment!
Visit Seeking Alpha's
BAX vs. ETF Alternatives
Company Description
Baxter International Inc is a healthcare company. It develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic conditions.